ENGLEWOOD, Colo., Jan. 28, 2014 (GLOBE NEWSWIRE) -- Innospec Inc. (Nasdaq:IOSP) today announced that it has appointed Jonathan Treen as Sales Director, Personal Care for its EMEA (Europe, Middle East & Africa) region, with effect from February 3, 2014.
With 30 years experience in the Personal Care business, Treen joins Innospec from Dow Corning. He will be responsible for leading all of the Innospec Personal Care team in EMEA and developing and implementing a sales growth strategy for the region.
Commenting on the appointment, Phil Boon, Executive Vice President, Business Operations at Innospec, said, "We have been strategically investing in our strategic Personal Care business, most recently with the acquisitions of Chemsil and Chemtec. We are delighted that Jonathan is joining our team. His proven track record of delivering growth and his extensive customer relationships and deep knowledge of the Personal Care market will be invaluable to us as we drive our business forward."
Jonathan Treen said, "I am pleased to be joining Innospec, in one of their strategic businesses, at a time when the focus is on growth and expansion. I'm looking forward to joining an energetic team and helping to grow this important business."
About Innospec Inc.
Innospec Inc. is an international specialty chemicals company with approximately 1,100 employees in 20 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Innospec's Fuel Specialties business specializes in manufacturing and supplying the fuel additives that help improve fuel efficiency, boost engine performance and reduce harmful emissions. Innospec's Performance Chemicals business provides effective technology-based solutions for our customers' processes or products focused in the Personal Care; Polymers; and Fragrance Ingredients markets. Innospec's Octane Additives business is the world's only producer of tetra ethyl lead.
This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like "expects," "anticipates," "may," "believes" or similar words or expressions), for example, which relate to operating performance, events or developments that we expect or anticipate will or may occur in the future (including, without limitation, any of the Company's guidance in respect of sales, gross margins, pension liabilities and charges, net income, growth potential and other measures of financial performance). Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to the Company and affecting our business operations and prospects are described in the Company's Annual Report on Form 10-K for the year ended December 31, 2012, and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading "Risk Factors" in such reports. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Brian Watt Innospec Inc. +44-151-356-6241 Brian.Watt@innospecinc.com Robert D. Ferris RF|Binder Partners +1-212-994-7505 Robert.Ferris@RFBinder.com Dan Scorpio RF|Binder Partners +1-212-994-7609 Dan.email@example.comSource:Innospec Inc.